radiopharmaceuticals
Radiopharmaceuticals are drugs that are bound to radioactive substances. The pharmaceutically active portion determines the activity that will be measured and the radioactive portion emits radiation that can be measured by the scanner.
A number of radiopharmaceuticals are used in human imaging. They share the physical characteristic of emitting radiation of various kinds. In some cases the emitted particles are detected either directly or indirectly by specialized equipment (e.g. SPECT, PET, gamma camera, etc.) to generate imaging. In other cases, the agent is used to have a tissue effect locally.
Properties of an ideal radiopharmaceutical:
- short physical half life time
- eliminated from the body with an effective half life time approximately equaling the examination time to prevent subsequent exposure to the body
- pure gamma emitter by isomeric transition
- gamma rays emitted should be monoenergetic (~150KeV)
- high specific activity
- localize largely and quickly at the target site
- decay into a more stable daughter nucleus
- easily and effectively attached to the chemical compound at room temperature
- cheap per patient dose
- can be easily produced or kept at the hospital site
Related Radiopaedia articles
Imaging technology
- imaging technology
- imaging physics
- imaging in practice
- x-ray
- x-ray physics
- x-ray in practice
- x-ray production
- x-ray tubes
- tube rating
- filters
- automatic exposure control (AEC)
- beam collimators
- grids
- air gap technique
- cassette
- intensifying screen
- x-ray film
- image intensifier
- digital radiography
- digital image
- mammography
- x-ray artifacts
- radiation units
- radiation safety
- radiation detectors
- fluoroscopy
- computed tomography (CT)
- CT physics
- CT in practice
- CT technology
- CT image reconstruction
- CT image quality
- CT spatial resolution
- CT contrast discrimination
- pitch
- noise in CT
- signal to noise ratio
- CT dose
- CT contrast media
- CT artifacts
- patient-based artifacts
- physics-based artifacts
- hardware-based artifacts
- ring artifact
- tube arcing
- out of field artifact
- air bubble artifact
- helical and multichannel artifacts
- CT safety
- history of CT
- MRI
- MRI physics
- MRI in practice
- MRI hardware
- signal processing
- MRI pulse sequences (basics | abbreviations | parameters)
- T1 weighted image
- T2 weighted image
- proton density weighted image
- chemical exchange saturation transfer
- CSF flow studies
- diffusion weighted imaging (DWI)
- echo-planar pulse sequences
- fat-suppressed imaging sequences
- gradient echo sequences
- inversion recovery sequences
- metal artifact reduction sequence (MARS)
- perfusion-weighted imaging
- techniques
- derived values
- saturation recovery sequences
- spin echo sequences
- spiral pulse sequences
- susceptibility-weighted imaging (SWI)
- T1 rho
- MR angiography (and venography)
- MR spectroscopy (MRS)
- 2-hydroxyglutarate peak: resonates at 2.25 ppm
- alanine peak: resonates at 1.48 ppm
- choline peak: resonates at 3.2 ppm
- citrate peak: resonates at 2.6 ppm
- creatine peak: resonates at 3.0 ppm
- functional MRI (fMRI)
- gamma-aminobutyric acid (GABA) peak: resonates at 2.2-2.4 ppm
- glutamine-glutamate peak: resonates at 2.2-2.4 ppm
- Hunter's angle
- lactate peak: resonates at 1.3 ppm
- lipids peak: resonates at 1.3 ppm
- myoinositol peak: resonates at 3.5 ppm
- MR fingerprinting
- N-acetylaspartate (NAA) peak: resonates at 2.0 ppm
- propylene glycol peak: resonates at 1.13 ppm
- MRI artifacts
- MRI hardware and room shielding
- central point artifact
- herringbone artifact
- inhomogeneity artifact
- moiré fringes
- RF overflow artifact
- zebra stripes
- zipper artifact
- MRI software
- patient and physiologic motion
- tissue heterogeneity and foreign bodies
- Fourier transform and Nyquist sampling theorem
- MRI hardware and room shielding
- MRI contrast agents
- MRI safety
- ultrasound
- ultrasound physics
- transducers
- linear array
- convex array
- phased array
- frame averaging (frame persistence)
- ultrasound image resolution
- imaging modes and display
- pulse-echo imaging
- grey-scale imaging
- time-gain compensation
- harmonic imaging
- real-time imaging
- Doppler imaging
- Doppler effect
- color Doppler
- power Doppler
- B flow
- color box
- Doppler angle
- pulse repetition frequency and scale
- wall filter
- color write priority
- packet size (dwell time)
- peak systolic velocity
- end-diastolic velocity
- resistive index
- pulsatility index
- Reynolds number
- panoramic imaging
- compound imaging
- harmonic imaging
- elastography
- scanning modes
- 2D ultrasound
- 3D ultrasound
- 4D ultrasound
- M-mode
- ultrasound artifacts
- acoustic shadowing
- acoustic enhancement
- beam width artifact
- reverberation artifact
- ring down artifact
- mirror image artifact
- side lobe artifact
- speckle artifact
- speed displacement artifact
- refraction artifact
- multipath artifact
- anisotropy
- electrical interference artifact
- hardware-related artifacts
- Doppler artifacts
- aliasing
- tissue vibration
- spectral broadening
- blooming
- motion (flash) artifact
- twinkling artifact
- acoustic streaming
- biological effects of ultrasound
- history of ultrasound
- pulse-echo imaging
- nuclear medicine
- nuclear medicine physics
- detectors
- tissue to background ratio
- radiopharmaceuticals
- fundamentals of radiopharmaceuticals
- radiopharmaceutical labeling
- radiopharmaceutical production
- nuclear reactor produced radionuclides
- cyclotron produced radionuclides
- radiation detection
- dosimetry
- specific agents
- carbon-11
- chromium-51
- fluorine agents
- gallium agents
- Ga-67 citrate
- Ga-68
- iodine agents
- I-123
- I-123 iodide
- I-123 ioflupane (DaTSCAN)
- I-123 ortho-iodohippurate
- I-131
- MIBG scans
- I-123 MIBG
- I-131 MIBG
- I-123
- indium agents
- In-111 Octreoscan
- In-111 OncoScint
- In-111 Prostascint
- In-111 oxine labeled WBC
- krypton-81m
- nitrogen-13
- oxygen-15
- phosphorus-32
- selenium-75
- technetium agents
- Tc-99m DMSA
- Tc-99m DTPA
- Tc-99m DTPA aerosol
- Tc-99m HMPAO
- Tc-99m HMPAO labeled WBC
- Tc-99m MAA
- Tc-99m MAG3
- Tc-99m MDP
- Tc-99m mercaptoacetyltriglycine
- Tc-99m pertechnetate
- Tc-99m labeled RBC
- Tc-99m sestamibi
- Tc-99m sulfur colloid
- Tc-99m sulfur colloid (oral)
- thallium-201 chloride
- xenon agents
- in vivo therapeutic agents
- erbium-169
- samarium-153
- strontium-89
- yttrium-90
- pharmaceuticals used in nuclear medicine
Siehe auch:
- Somatostatin-Rezeptor-Szintigrafie
- technetium radiopharmaceuticals
- Tc-99m sulphur colloid
- tc-99m DTPA
- tc-99m sestamibi
- tc-99m MAA
- tc-99m MAG3
- tc-99m DMSA
- I 123
- Physical half life time
- effective half life time
- MIBG scans
- Tc 99 Pertechnetate
- Tc-99m DTPA aerosol
- Xenon
und weiter:
Assoziationen und Differentialdiagnosen zu radiopharmaceuticals: